EA201990630A1 - Устойчивые к антисептику молочнокислые бактерии - Google Patents

Устойчивые к антисептику молочнокислые бактерии

Info

Publication number
EA201990630A1
EA201990630A1 EA201990630A EA201990630A EA201990630A1 EA 201990630 A1 EA201990630 A1 EA 201990630A1 EA 201990630 A EA201990630 A EA 201990630A EA 201990630 A EA201990630 A EA 201990630A EA 201990630 A1 EA201990630 A1 EA 201990630A1
Authority
EA
Eurasian Patent Office
Prior art keywords
lactic acid
acid bacteria
antiseptic
strains
resistant lactic
Prior art date
Application number
EA201990630A
Other languages
English (en)
Russian (ru)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of EA201990630A1 publication Critical patent/EA201990630A1/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02Local antiseptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/025Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11Medicinal preparations comprising living procariotic cells
    • A61K2035/115Probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Birds (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Immunology (AREA)
EA201990630A 2016-10-03 2017-09-29 Устойчивые к антисептику молочнокислые бактерии EA201990630A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16382453 2016-10-03
PCT/EP2017/074844 WO2018065324A1 (en) 2016-10-03 2017-09-29 Antiseptic-tolerant lactic acid bacteria

Publications (1)

Publication Number Publication Date
EA201990630A1 true EA201990630A1 (ru) 2019-10-31

Family

ID=57123946

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201990630A EA201990630A1 (ru) 2016-10-03 2017-09-29 Устойчивые к антисептику молочнокислые бактерии

Country Status (12)

Country Link
US (1) US10850135B2 (enExample)
EP (1) EP3519557A1 (enExample)
JP (1) JP7068286B2 (enExample)
KR (1) KR102476856B1 (enExample)
CN (1) CN109890955B (enExample)
AU (1) AU2017339033B2 (enExample)
CA (1) CA3038868A1 (enExample)
EA (1) EA201990630A1 (enExample)
MX (1) MX379324B (enExample)
MY (1) MY191734A (enExample)
PH (1) PH12019500714A1 (enExample)
WO (1) WO2018065324A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102036275B1 (ko) * 2018-10-02 2019-10-24 서울대학교 산학협력단 항-염증 활성이 우수한 페디오코커스 악시딜락티시 ldtm 5201 신균주(kctc 13563bp)
CN110819558B (zh) * 2019-10-16 2022-07-05 天津科技大学 一种乳酸片球菌aaf 3-3及其用途
WO2021183085A2 (en) * 2020-03-12 2021-09-16 Hly Aromaterapi̇ Hi̇zmetleri̇ Kozmeti̇k Sanayi̇ Ti̇caret Anoni̇m Şi̇rketi̇ Probiotic and oil combination
TWI748395B (zh) * 2020-03-31 2021-12-01 豐華生物科技股份有限公司 緩解過敏以及提升運動表現之組合物及其用途
TR202006605A2 (tr) * 2020-04-28 2020-06-22 Hly Aromaterapi Hizmetleri Kozmetik Sanayi Ticaret Anonim Sirketi Aynisefa yaği i̇çeren multi̇ probi̇yoti̇k yağ kombi̇nasyonu ve üreti̇m yöntemi̇
WO2021221594A2 (en) * 2020-04-30 2021-11-04 Hly Aromaterapi̇ Hi̇zmetleri̇ Kozmeti̇k Sanayi̇ Ti̇caret Anoni̇m Şi̇rketi̇ Multi-probiotic oil combination containing borage oil and production method thereof
CN111826324A (zh) * 2020-08-05 2020-10-27 厦门惠盈动物科技有限公司 一种鼠李糖乳杆菌菌粉的制备方法
JP2024506463A (ja) * 2021-01-05 2024-02-14 ラクトバイオ アー/エス 菌株、組成物および使用方法
CN112675182A (zh) * 2021-01-14 2021-04-20 吉林大学 水杨酸甲酯在制备沙门氏菌ⅲ型分泌系统抑制剂中的应用
KR102562773B1 (ko) * 2021-07-05 2023-08-02 동국대학교 산학협력단 페디오코쿠스 에시디락티시의 gDNA를 포함하는 구강 염증 질환 예방 또는 치료용 약학 조성물
AU2023233349A1 (en) * 2022-03-17 2024-10-10 Kaneka Corporation Glucuronidase activator, pharmaceutical composition, edible composition, and composition for oral application
JP2023172607A (ja) * 2022-05-24 2023-12-06 株式会社アデランス 乳酸菌含有ガム
CN116464031A (zh) * 2023-04-19 2023-07-21 海南大学 一种岛礁珊瑚填料挤密桩及其施工方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0303678D0 (en) 2003-02-18 2003-03-19 Quest Int Improvements in or relating to flavour compositions
KR20110019803A (ko) 2009-08-21 2011-03-02 신미정 향이 첨가된 치주 질환의 예방 및 치료용 유산균 분말 세정제
DE202009011379U1 (de) * 2009-08-24 2010-12-30 Khalifa, Samir Orale Präparate zur Mund- und Zahnpflege und Bekämpfung von Mundgeruch
EP2420580A1 (en) 2010-08-18 2012-02-22 AB-Biotics, S.A. Probiotic composition for oral health
KR101804145B1 (ko) * 2013-08-14 2017-12-04 울산과학기술원 대장균의 지놈 엔지니어링용 플라스미드 및 이를 이용한 대장균의 지놈 엔지니어링 방법
US9554986B2 (en) * 2014-07-30 2017-01-31 Nelson Harvey Oral care composition
EP3117822A1 (en) 2015-07-17 2017-01-18 AB-Biotics, S.A. Self-film-forming composition for oral care

Also Published As

Publication number Publication date
AU2017339033B2 (en) 2024-04-18
AU2017339033A1 (en) 2019-04-18
CN109890955A (zh) 2019-06-14
PH12019500714A1 (en) 2019-08-05
KR20190062477A (ko) 2019-06-05
MX2019003787A (es) 2019-09-26
WO2018065324A1 (en) 2018-04-12
US20190247681A1 (en) 2019-08-15
BR112019006653A2 (pt) 2019-07-02
CN109890955B (zh) 2023-05-09
JP7068286B2 (ja) 2022-05-16
MX379324B (es) 2025-03-11
CA3038868A1 (en) 2018-04-12
JP2019533655A (ja) 2019-11-21
US10850135B2 (en) 2020-12-01
EP3519557A1 (en) 2019-08-07
MY191734A (en) 2022-07-13
KR102476856B1 (ko) 2022-12-12

Similar Documents

Publication Publication Date Title
EA201990630A1 (ru) Устойчивые к антисептику молочнокислые бактерии
CY1122585T1 (el) Συνδυασμοι που περιλαμβανουν παραγωγα 5-φαινοξυ-3η-πυριμιδιν-4-ονης και η χρηση αυτων για την προφυλαξη ή αγωγη λοιμωξης απο ηiv
MX2019007262A (es) Compuestos antivirales de bencilamina fosfodiamida.
EA201690147A1 (ru) Пероральные композиции
EA201590457A1 (ru) Сульфамоил-ариламиды и их применение в качестве лекарственных препаратов для лечения гепатита b
WO2017042607A3 (en) Compositions comprising meloxicam-cyclodextrin inclusion complexes and methods of treating acute pain
ECSP12012201A (es) Inhibidores no nucleosídicos de la transcriptasa inversa
MX348653B (es) Derivados ester de acido boronico ciclico y sus usos terapeuticos.
EA201890633A1 (ru) Композиции и способы для многофункциональных растворов для дезинфекции и стерилизации
MX2015010003A (es) Triterpenoides c-19 modificados, con actividad inhibidora de la maduracion del virus de inmunodeficiencia humana (vih).
MX2016012915A (es) Profarmacos de inhibidores de la transcriptasa inversa del virus de la inmunodeficiencia humana (vih).
PH12017500637A1 (en) Inhibitors of lysine gingipain
ZA202002093B (en) Antibacterial compounds
TN2016000435A1 (en) Novel macrocyclic compounds.
UA120927C2 (uk) Тритерпеноїди, заміщені в положенні 3 неароматичним кільцем, яке несе галогеналкільний замісник, з інгібуючою активністю щодо дозрівання віл
WO2015017393A3 (en) Piperazine derivatives as hiv protease inhibitors
MX379201B (es) Derivados de 3-(carboxietil)-8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano.
MX378995B (es) Derivados de 3-(carboximetil)-8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano.
DOP2021000069A (es) Derivados de 4 pirazin-2-ilmetil-morfolina y su uso como medicamento
UY36273A (es) Composicion para el tratamiento de neuropatías y del dolor neuropático
BR112016029619A2 (pt) novas fluoroquinolonas e sesu usos no tratamento de infecções bacterianas
WO2015035234A3 (en) Anti-microbial compounds and compositions
PL431336A1 (pl) Lipopeptydy, kompozycja farmaceutyczna, kompozycja kosmetyczna oraz lipopeptydy do zastosowania jako lek
Nagoba et al. Use Of Turpentine Oil For Easy Extraction Of Maggots In Vaginal Myiasis
HK1234745A1 (en) Inhibitors of lysine gingipain